Zobrazeno 1 - 10
of 24
pro vyhledávání: '"E Lacalle Fabo"'
Publikováno v:
Neurology Perspectives, Vol 2, Iss 2, Pp 102-104 (2022)
Externí odkaz:
https://doaj.org/article/3ef33568a4e64a7ca524e426a4f738dd
Autor:
G Pinilla Lebrero, E Lacalle Fabo, P Aldave Cobos, L Ulacia Epelde, JA Illodo Becerra, J.J. Elizondo Armendáriz, D Fresan Restituto, M Sarobe Carricas, J Polo García, M Calvo Arbeloa
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Severe uncontrolled asthma is characterised by poor control despite treatment with inhaled glucocorticoids (IGC) and beta2 adrenergic agonists (LABA) at high doses, and/or oral glucocorticoids (OGC). This type of asthma comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7f3ac6438d21ea68b69b9fd181c409f
https://doi.org/10.1136/ejhpharm-2020-eahpconf.243
https://doi.org/10.1136/ejhpharm-2020-eahpconf.243
Autor:
E Lacalle-Fabo, Marta Gutiérrez-Valencia, M Castresana-Elizondo, MP Monforte-Gasque, A Galbete, Nicolás Martínez-Velilla
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Anticholinergic burden of medications has been linked to a number of adverse outcomes in older adults. It has demonstrated a negative impact on health outcomes such as cognitive impairment or falls, and many studies have recently investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::379c4d33be35992805059106aaed6afb
https://doi.org/10.1136/ejhpharm-2019-eahpconf.565
https://doi.org/10.1136/ejhpharm-2019-eahpconf.565
Autor:
Nicolás Martínez-Velilla, E Lacalle-Fabo, Marta Gutiérrez-Valencia, M Castresana-Elizondo, J Alonso-Renedo, MP Monforte-Gasque
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Treatment adherence is a very important issue in ensuring the correct effectiveness of treatments, and it is often compromised in older patients. To assess and improve patients’ treatment adherence is an important role of clinical pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d63dd852dad65f3a67bac66791bac94
https://doi.org/10.1136/ejhpharm-2019-eahpconf.375
https://doi.org/10.1136/ejhpharm-2019-eahpconf.375
Autor:
M Castresana-Elizondo, E Lacalle-Fabo, J Alonso-Renedo, MP Monforte-Gasque, Marta Gutiérrez-Valencia, Nicolás Martínez-Velilla
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Older adults are at high risk of adverse drugs events (ADEs) and these are often a cause of hospitalisation in this population. Factors associated with drug-related hospital admissions are not well known. Purpose To estimate the prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::619e5e6b79e258fe7f3d17f33d93d8e8
https://doi.org/10.1136/ejhpharm-2019-eahpconf.566
https://doi.org/10.1136/ejhpharm-2019-eahpconf.566
Autor:
E Lacalle Fabo, I. Beobide Telleria, B. Larrayoz Sola, Matteo Tosato, N. Martínez Velilla, M. Gutiérrez Valencia
Publikováno v:
Revista Clínica Española (English Edition). 216:205-221
Objective To summarise the evidence on interventions aimed at optimising the drug treatment of hospitalised elderly patients. Material and methods We conducted a search in the main medical literature databases, selecting prospective studies of hospit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::255b7b9a57be6d0554a74dab368ee6af
https://doi.org/10.1016/j.rceng.2016.01.004
https://doi.org/10.1016/j.rceng.2016.01.004
Autor:
E Lacalle Fabo, J Alfaro Basarte, M Castresana Elizondo, E. Pellejero Hernando, MP Monforte Gasque, R Astiz Lizarraga, M. Gutiérrez Valencia, M Elviro Llorens, I Hernández García
Publikováno v:
Clinical pharmacy.
Background Panitumumab is a fully human monoclonal antibody Ig G2 whose target is the epidermal growth factor receptor (EGFR). It is indicated as monotherapy to treat patients with metastatic colorectal cancer (mCRC) that show EGFR with wild-type KRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5168d2844133c99f6dc217304e264974
https://doi.org/10.1136/ejhpharm-2017-000640.220
https://doi.org/10.1136/ejhpharm-2017-000640.220
Autor:
M, Gutiérrez Valencia, N, Martínez Velilla, E, Lacalle Fabo, I, Beobide Telleria, B, Larrayoz Sola, M, Tosato
Publikováno v:
Revista clinica espanola. 216(4)
To summarise the evidence on interventions aimed at optimising the drug treatment of hospitalised elderly patients.We conducted a search in the main medical literature databases, selecting prospective studies of hospitalised patients older than 65 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b02b3f170f0e61601e8279926364361b
https://pubmed.ncbi.nlm.nih.gov/26899140
https://pubmed.ncbi.nlm.nih.gov/26899140
Autor:
I Monteserin Garrastatxu, R Rodil Fraile, M Sarobe Carricas, E Lacalle Fabo, M. Gutiérrez Valencia, M Castresana Elizondo, J Fernández González, M Etxeberria Uriz, MP Monforte Gasque
Publikováno v:
European Journal of Hospital Pharmacy. 23:A157.1-A157
Background Tuberous sclerosis complex (TSC) is an autosomal dominant disease with variable expressiveness and multisystem involvement. Everolimus, an mTOR inhibitor, is indicated for the treatment of kidney angiomyolipoma and subependymal giant cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::761c9edf0898b7387a9346e1401f278a
https://doi.org/10.1136/ejhpharm-2016-000875.354
https://doi.org/10.1136/ejhpharm-2016-000875.354
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.